chloroquine has been researched along with fosmidomycin monosodium salt in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, S; Arnett, SD; Ball, H; Boshoff, HI; Brothers, RC; Couch, RD; Dowd, CS; Edwards, RL; Girma, M; Haymond, A; Johnson, C; Manikkam, M; McKay, KT; Meyers, MJ; Odom John, AR; Osbourn, DM; Wang, X | 1 |
| Caljon, G; Cos, P; Courtens, C; Martin, A; Risseeuw, M; Van Calenbergh, S | 1 |
| Caljon, G; Cos, P; Courtens, C; Maes, L; Martin, A; Risseeuw, M; Van Calenbergh, S | 1 |
3 other study(ies) available for chloroquine and fosmidomycin monosodium salt
| Article | Year |
|---|---|
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
Topics: Aldose-Ketose Isomerases; Animals; Antimalarials; Female; Fosfomycin; Malaria, Falciparum; Mice; Plasmodium falciparum; Prodrugs; Structure-Activity Relationship | 2018 |
Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Topics: Antimalarials; Antitubercular Agents; Cell Line; Cell Survival; Fosfomycin; Humans; Hydroxamic Acids; Mycobacterium tuberculosis; Organophosphonates; Plasmodium falciparum; Prodrugs | 2019 |
Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Topics: Antimalarials; Antitubercular Agents; Carbamates; Drug Evaluation, Preclinical; Fosfomycin; Humans; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Plasmodium falciparum; Prodrugs; Signal Transduction; Structure-Activity Relationship | 2019 |